COGT — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

11.15

Margin Of Safety %

Put/Call OI Ratio

0.11

EPS Next Q Diff

0.08

EPS Last/This Y

-0.14

EPS This/Next Y

0.98

Price

28.53

Target Price

55.82

Analyst Recom

1.17

Performance Q

-24.58

Upside

-406.4%

Beta

0.35

Ticker: COGT

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-15	COGT	29.59	0.12	0.94	29678
2026-10-16	COGT	29.54	0.12	1.00	29909
2026-10-19	COGT	30.02	0.11	0.02	26764
2026-10-20	COGT	31.24	0.11	0.12	26960
2026-10-21	COGT	31.47	0.12	0.06	28241
2026-10-22	COGT	31.32	0.12	0.03	28080
2026-10-23	COGT	31.19	0.12	0.13	28121
2026-10-26	COGT	30.83	0.12	0.14	28198
2026-10-27	COGT	32.03	0.12	0.02	28203
2026-10-28	COGT	32.25	0.12	0.09	28244
2026-10-29	COGT	31.88	0.12	0.07	28329
2026-10-30	COGT	31.01	0.12	0.01	28197
2026-11-02	COGT	29.72	0.12	0.01	28132
2026-11-03	COGT	31.05	0.12	0.02	27504
2026-11-04	COGT	31.45	0.12	0.06	28801
2026-11-05	COGT	29.55	0.12	0.13	28866
2026-11-06	COGT	31.62	0.12	0.01	28917
2026-11-09	COGT	33.56	0.11	0.02	33380
2026-11-10	COGT	31.64	0.11	0.08	33345
2026-11-11	COGT	29.39	0.11	0.14	33362
2026-11-12	COGT	29.17	0.11	3.42	34939
2026-11-13	COGT	28.56	0.11	2.88	35093
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-15	COGT	29.51	-9.5	-	-2.21
2026-10-16	COGT	29.53	-9.5	-	-2.21
2026-10-19	COGT	30.01	-9.5	-	-2.21
2026-10-20	COGT	30.01	-9.5	-	-2.21
2026-10-21	COGT	31.22	-9.5	-	-2.21
2026-10-22	COGT	31.32	-9.5	-	-2.21
2026-10-23	COGT	31.18	-9.5	-	-2.21
2026-10-26	COGT	30.91	-10.0	-	-2.22
2026-10-27	COGT	32.01	-10.0	-	-2.22
2026-10-28	COGT	32.24	-10.0	-	-2.22
2026-10-29	COGT	31.98	-10.0	-	-2.22
2026-10-30	COGT	31.02	-10.0	-	-2.22
2026-11-02	COGT	29.73	-10.0	-	-2.22
2026-11-03	COGT	31.06	-10.0	-	-2.22
2026-11-04	COGT	31.47	-10.0	-	-2.22
2026-11-05	COGT	29.55	-10.0	-	-2.22
2026-11-06	COGT	31.64	-10.0	-	-2.22
2026-11-09	COGT	33.56	-10.0	-	-2.22
2026-11-10	COGT	31.61	-3.0	-	-2.22
2026-11-11	COGT	29.39	-7.0	-	-2.26
2026-11-12	COGT	29.15	-7.0	-	-2.26
2026-11-13	COGT	28.53	-10.9	-	-2.30
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-15	COGT	-0.26	4.60	12.49
2026-10-16	COGT	-0.26	4.60	12.49
2026-10-19	COGT	-0.26	4.68	12.49
2026-10-20	COGT	-0.26	4.68	12.49
2026-10-21	COGT	-0.26	4.68	12.49
2026-10-22	COGT	-0.26	4.68	12.49
2026-10-23	COGT	-0.26	4.68	12.49
2026-10-26	COGT	-0.26	3.61	12.49
2026-10-27	COGT	-0.26	3.61	12.62
2026-10-28	COGT	-0.26	3.61	12.62
2026-10-29	COGT	-0.26	3.61	12.62
2026-10-30	COGT	-0.26	3.61	12.62
2026-11-02	COGT	-0.26	3.50	12.62
2026-11-03	COGT	-0.26	3.50	12.62
2026-11-05	COGT	-0.26	3.50	12.62
2026-11-06	COGT	-0.26	3.50	12.62
2026-11-09	COGT	-0.26	3.67	12.58
2026-11-10	COGT	-0.26	3.67	12.58
2026-11-11	COGT	-0.26	3.67	11.15
2026-11-12	COGT	-0.26	3.67	11.15
2026-11-13	COGT	-0.26	3.67	11.15
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.59

Avg. EPS Est. Current Quarter

-0.62

Avg. EPS Est. Next Quarter

-0.52

Insider Transactions

-0.26

Institutional Transactions

3.67

Beta

0.35

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

34.8

Max Drawdown 5-Year %

-76.3

Target Price

55.82

P/E

Forward P/E

PEG

P/S

P/B

11.01

P/Free Cash Flow

EPS

-2.5

Average EPS Est. Cur. Y

-2.3

EPS Next Y. (Est.)

-1.32

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.55

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-86.2

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.09

EBIT Estimation

◆ COGT Healthcare

$28.56

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

14/20

Pullback

12/25

Volume

8/15

Valuation

12/20

TP/AR

3/10

Options

5/10

RSI

40.8

Range 1M

15.6%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

10/25

Growth

10/30

Estimates

2/20

Inst/Vol

4/15

Options

7/10

EPS Yr

-7.3%

EPS NY

48.9%

52W%

6.2%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +95.4% upside

Quality

2/30

Valuation

14/30

Growth

7/25

Stability

8/10

LT Trend

4/5

Upside

+95.4%

Quality

COGT — P/E HistoricalBiotechnology

Cogent Biosciences, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 258

Cogent Biosciences, Inc., a clinical-stage biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyrosine kinase inhibitor in Phase 3 trial designed to target mutations within the KIT receptor tyrosine kinase, including KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. The company also develops CGT4859, a reversible and selective fibroblast growth factor receptor 2 inhibitor in Phase 1 trial for patients with documented FGFR mutations, including advanced cholangiocarcinoma; CGT4255, a novel ErbB2 mutant program, which is focused on actionable and underserved mutations in a solid tumor systemic and CNS involved indications; and CGT6297, a Novel PI3Ka mutant-selective inhibitor. It has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. Cogent Biosciences, Inc. is headquartered in Waltham, Massachusetts.

COGT

Latest News

—

Caricamento notizie per COGT…

stock quote shares COGT – Cogent Biosciences Inc Stock Price stock today

news today COGT – Cogent Biosciences Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch COGT – Cogent Biosciences Inc yahoo finance google finance

stock history COGT – Cogent Biosciences Inc invest stock market

stock prices COGT premarket after hours

ticker COGT fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: COGT

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y